The Effect of Inhaled Budesonide on the Maximal Degree of Airway Narrowing to Leukotriene D4and Methacholine in Normal SubjectsIn Vivo
- 1 February 1989
- journal article
- research article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 139 (2) , 427-431
- https://doi.org/10.1164/ajrccm/139.2.427
Abstract
In normal humans in vivo, maximal airway narrowing to LTD4 is more severe than to methacholine. Moreover, LTD4 heightens the maximal response to methacholine for several days. To investigate whether or not this is due to inflammatory changes in the airway wall, we studied the effects of the corticosteroid budesonide on the dose-response curves to inhaled LTD4 and to methacholine. In a two-period, double-blind, placebo-controlled design, budesonide (400 µg twice a day) or placebo was inhaled by eight normal subjects on six consecutive days, with a 3-wk washout. Complete dose-response curves to LTD4 (0.36 to 43 nmol) were performed on Day 5, and to methacholine (1.28 to 655 µmol) on Days 4 and 6 of each period using a validated method. The response was measured by FEV1 and standardized partial expiratory flow-volume curves ( 40p), and was expressed as the percent fall from baseline. A maximal response plateau was considered if more than two doses fell within a 5% response range. All subjects reached plateaus to methacholine and to LTD4. Budesonide reduced the maximal response to LTD4 (mean difference with placebo, 7.9% fall for FEV1, and 8.4% fall for 40p; p < 0.05). During placebo the maximal response to methacholine 24 h after LTD4 was higher than 24 h before (mean change, 2.7% fall in FEV1 and 5.5% fall in 40p; p < 0.05), but not during budesonide (mean change, −2.5% fall in FEV1 and −0.1% fall in 40p; p > 0.2), the changes being significantly different between the two periods (p < 0.05). Budesonide did not affect the position of the respective dose-response curves. We conclude that inhaled steroids reduce the maximal degree of airway narrowing to LTD4 and protect against the LTD4-induced increase in maximal response to methacholine. This is in support of the hypothesis that inflammatory changes account for the excessive airway narrowing observed in asthma.This publication has 24 references indexed in Scilit:
- Leukotrienes and Related EicosanoidsAmerican Review of Respiratory Disease, 1987
- Maximal Airway Narrowing to Inhaled Leukotriene D4in Normal Subjects: Comparison and Interaction with MethacholineAmerican Review of Respiratory Disease, 1987
- Leukotrienes and the Pulmonary MicrocirculationAmerican Review of Respiratory Disease, 1987
- Lipid-derived and other chemical mediators of inflammation in the lungJournal of Allergy and Clinical Immunology, 1987
- Mode of action of corticosteroids in asthma and rhinitisClinical and Experimental Allergy, 1986
- Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutalineJournal of Allergy and Clinical Immunology, 1985
- PHARMACOLOGY OF LEUKOTRIENESBritish Medical Bulletin, 1983
- Pharmacological study of the contractile activity of leukotriene C4 and D4 on isolated human airway smooth muscleCanadian Journal of Physiology and Pharmacology, 1982
- Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.Proceedings of the National Academy of Sciences, 1981
- The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skinProstaglandins, 1981